Aemetis, Inc. (NASDAQ:AMTX) Shares Purchased by Barclays PLC

Barclays PLC boosted its stake in Aemetis, Inc. (NASDAQ:AMTX) by 274.6% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 47,496 shares of the specialty chemicals company’s stock after purchasing an additional 34,816 shares during the period. Barclays PLC’s holdings in Aemetis were worth $109,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in AMTX. State Street Corp increased its position in Aemetis by 36.1% in the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after acquiring an additional 185,304 shares during the period. Bank of New York Mellon Corp acquired a new position in Aemetis in the 2nd quarter valued at about $306,000. Susquehanna Fundamental Investments LLC increased its position in Aemetis by 287.4% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after acquiring an additional 93,536 shares during the period. Wellington Management Group LLP acquired a new position in Aemetis in the 3rd quarter valued at about $177,000. Finally, Rhumbline Advisers increased its position in Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after acquiring an additional 50,528 shares during the period. Institutional investors and hedge funds own 27.02% of the company’s stock.

Wall Street Analyst Weigh In

AMTX has been the topic of several recent research reports. HC Wainwright restated a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research report on Monday, December 23rd. StockNews.com upgraded Aemetis to a “sell” rating in a research report on Friday, January 3rd. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, Aemetis presently has a consensus rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Trading Down 2.8 %

NASDAQ AMTX opened at $2.82 on Thursday. The business’s 50 day moving average is $3.28 and its two-hundred day moving average is $2.97. Aemetis, Inc. has a 12-month low of $2.10 and a 12-month high of $7.03. The stock has a market capitalization of $140.25 million, a price-to-earnings ratio of -1.25 and a beta of 1.47.

Aemetis (NASDAQ:AMTX) last released its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same quarter in the previous year, the firm posted ($0.59) EPS. Equities analysts forecast that Aemetis, Inc. will post -2.02 earnings per share for the current fiscal year.

Aemetis Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.